Dyadic to Present at the Prudential Equity Group, LLC ``Inside Our Best Ideas'' Conference on September 27, 2006 at 9:30 a.m. ED
2006年9月21日 - 9:02PM
ビジネスワイヤ(英語)
Dyadic International, Inc. (AMEX:DIL), a biotechnology company,
announced today that Mark Emalfarb, Dyadic's President and Chief
Executive Officer, will make a presentation at the Prudential
Equity Group, LLC "Inside Our Best Ideas" Conference to be held at
the Grand Summit Resort Hotel in Mount Snow, Vermont, on September
27-29, 2006. Mr. Emalfarb's presentation is scheduled for September
27 at 9:30 a.m. EDT. A simultaneous webcast of the presentation may
be accessed by clicking the webcast link at http://www.dyadic.com.
A replay will be available for 30 days at the same internet
address. "The 60-minute format for this presentation will give me
time to provide an in-depth analysis of Dyadic's technologies,
current activities, and strategy for the future," Mr. Emalfarb
said. Mr. Emalfarb plans to discuss Dyadic's progress in the
development of its proprietary enabling platform technologies,
which are broadly applicable for the discovery, development and
large-scale production of new, improved and/or more affordable
products in three core business areas: -- Biorefineries, including
the Company's recent advances in the development of its patented
and proprietary enzyme mixtures to make abundant low-cost sugars
from agricultural plant materials. Sugars can be used in place of
petroleum to produce ethanol, plastics and polymers in a variety of
manufacturing and refining processes. -- Biosciences, updating
Dyadic's efforts to leverage its patented C1 Host Technology to
facilitate more efficient discovery, development and production of
new, improved and/or more affordable human antibodies, as well as
other protein drugs; and, -- Enzymes, detailing the Company's
progress in expanding its Enzyme Business beyond textiles to larger
and more profitable markets including pulp and paper and animal
feed. About Dyadic Dyadic International, Inc., based in Jupiter,
Florida, with operations in the United States of America, Hong Kong
and mainland China, Poland and The Netherlands, is engaged in the
development, manufacture and sale of biological products using a
number of proprietary fungal strains to produce enzymes and other
biomaterials, principally focused on a system for protein
production based on the patented Chrysosporium lucknowense fungus,
known as C1. Dyadic is applying its technologies to produce enzymes
for use in converting various agricultural products (e.g. corn) and
waste products (e.g. switch grass, wheat straw, sugar cane bagasse,
etc.) into fermentable sugars, which can then be used in the
production of traditional and cellulosic ethanol as well as other
products currently derived from petroleum. Dyadic's C1 technology
also is being developed to facilitate the discovery, development
and large-scale production of human antibodies and other high-value
therapeutic proteins. Dyadic currently sells more than 45 liquid
and dry enzyme products to more than 200 industrial customers in
approximately 50 countries for the textile, pulp & paper,
animal feed, alcohol, starch, and food and beverage industries.
Cautionary Statement for Forward-Looking Statements Certain
statements contained in this press release are "forward-looking
statements." These forward-looking statements involve risks and
uncertainties that could cause our actual results, performance or
achievements to be materially different from any future results,
performance or achievements expressed or implied by such
forward-looking statements. For a discussion of these risks and
uncertainties, please see our filings from time to time with the
Securities and Exchange Commission, which are available free of
charge on the SEC's web site at http://www.sec.gov, including our
Annual Report on Form 10-KSB for the year ended December 31, 2005,
and our subsequent filings with the SEC. Except as required by law,
we expressly disclaim any intent or obligation to update any
forward-looking statements.
Dyadic (AMEX:DIL)
過去 株価チャート
から 8 2024 まで 9 2024
Dyadic (AMEX:DIL)
過去 株価チャート
から 9 2023 まで 9 2024